Pepdox
Studies
Peptides
Calculator
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. | Pepdox
Home
/
Search
/
PMID 28252261
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
The New England journal of medicine
2017
PMID: 28252261
View on PubMed
DOI: 10.1056/NEJMc1615712
Semaglutide
Authors
Cosmi, Franco; Laini, Roberto; Nicolucci, Antonio